About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
2026 Grads

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

17.89 +0.44 (+2.52%)

Streaming Delayed Price Updated: 2:20 PM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Churchill Capital Corp XI - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

ChemoCentryx Stock Needs To Hold At Support Or It May Slide Lower ↗

September 30, 2021

ChemoCentryx Inc (NASDAQ: CCXI) shares are trading lower Thursday, although there looks to be no company-evident news to explain the jump in share price. The stock was...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 30, 2021

Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity...

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

September 30, 2021

Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations program. Farmmi, Inc. (NASDAQ: FAMI) jumped 45.5...

Via Benzinga

Analyzing ChemoCentryx's Unusual Options Activity ↗

August 09, 2021

Shares of ChemoCentryx (NASDAQ:CCXI) saw some unusual opt...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Analyst Ratings For ChemoCentryx ↗

July 07, 2021

Analysts have provided the following ratings for ChemoCentryx (NASDAQ:

Via Benzinga

Why This ChemoCentryx Analyst Is Bullish ↗

July 06, 2021

H.C. Wainwright analysts remain bullish on ChemoCentryx, Inc. (NASDAQ:

Via Benzinga

Why Are ChemoCentryx's Shares Trading Higher Today? ↗

September 27, 2021

ChemoCentryx Inc's (NASDAQ: CCXI) partner Kissei Pharmaceutical Co Ltd has received approval from the Japanese Ministry of Health, Labor, and Welfare...

Via Benzinga

22 Stocks Moving in Friday's Pre-Market Session ↗

September 24, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month. vTv Therapeutics Inc...

Via Benzinga

2 Growth Stocks That Could Take Off Before the End of the Year ↗

September 16, 2021

They've been struggling thus far in 2021, but things could turn around quickly for these companies.

Via The Motley Fool

NASDAQ:CCXI Long Term Shareholder Notice: Investigation over Potential Wrongdoing at ChemoCentryx, Inc. ↗

September 15, 2021

San Diego, CA -- (SBWIRE) -- 09/15/2021 -- Certain directors of ChemoCentryx, Inc. are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

Topics Lawsuit

ChemoCentryx's Return On Capital Employed Overview ↗

September 13, 2021

Benzinga Pro data, ChemoCentryx (NASDAQ:CCXI) reported Q2 sales of $1.81 million. Earnings fell to a loss of $38.74 million, resulting in a 32.09% decrease from last quarter. In...

Via Benzinga

ChemoCentryx, inc (CCXI) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

CCXI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

ChemoCentryx: Q2 Earnings Insights ↗

August 09, 2021

Shares of ChemoCentryx (NASDAQ:CCXI) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 293.10% year over year to ($0.56...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates ↗

August 02, 2021

The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

August 02, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

Analyzing ChemoCentryx's Unusual Options Activity ↗

July 29, 2021

ChemoCentryx (NASDAQ:CCXI) shares experienced unusual options activity on Thursday. The stock price moved down to $15.19 following the option alert. Sentiment: BULLISH Option...

Via Benzinga

2 Beaten-Down Biotech Stocks That Could Bounce Back ↗

July 27, 2021

The market hasn't been kind to these two drugmakers, but both have a chance to turn things around.

Via The Motley Fool

The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix ↗

July 11, 2021

Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...

Via Benzinga

Is Now the Time to Buy ChemoCentryx Stock? ↗

July 10, 2021

Analysts following this risky biotech stock have changed their tune.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021 ↗

July 07, 2021

Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

July 07, 2021

Keybanc cut Alibaba Group Holding Limited (NYSE: BABA) price target from $275 to $270. Alibaba shares rose 0.5% to $212.60 in pre-market trading. Needham boosted SMART Global...

Via Benzinga

ChemoCentryx Stock Is Approaching A Key Level ↗

July 06, 2021

ChemoCentryx Inc. (NASDAQ: CCXI) shares traded higher Tuesday after the company announced it filed an amendment to its New Drug Application for avacopan for the treatment of anti-...

Via Benzinga

ChemoCentryx Stock Jumps On Amendment In Avacopan Application, New Goal Date Of October 7 ↗

July 06, 2021

Following consultations with the FDA, ChemoCentryx Inc (NASDAQ: CCXI) filed an amendment to its marketing application seeking approval for avacopan to treat...

Via Benzinga

Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗

July 03, 2021

Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to...

Via Talk Markets

Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗

July 03, 2021

Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off...

Via Benzinga

CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit

July 03, 2021

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week ↗

July 03, 2021

Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few...

Via Benzinga

CHEMOCENTRYX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ChemoCentryx, Inc. - CCXI

July 02, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm

July 02, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

All News about Churchill Capital Corp XI - Class A Ordinary Shares

Sections

Services

Contact Information

Follow Us